|
Introduction
Ana-Gen offers two (2) different methods of Prenatal testing:
First, Amniocentesis, where a small sample of amniotic fluid from
mother's amniotic sac is withdrawn and DNA is extracted. The extracted
DNA is used to determine paternity. Second, Chorionic Villus,
which is a procedure whereby a small sample of chorionic
(placental) tissue is removed for prenatal diagnosis, such as
paternity.
Explanation of the DNA
Prenatal Paternity Tests
Amniocentesis
In the procedure of Amniocentesis, a
hollow needle is inserted through the abdominal wall into the
placenta to remove some of the amniotic fluid that surrounds the fetus under
ultrasound guidance. The fluid extracted contains cells
that are shed primarily from the fetal skin, bladder,
gastrointestinal tract, and amnion. Cultures are created using these
cells and cells are used to test for genetic abnormalities and
paternity. The ideal time to perform Amniocentesis is between the
15th and 18th weeks of pregnancy but could be performed as early as 12th week or as late as 20th. Amniocentesis performed before the
14th week has been shown to carry a higher risk of miscarriage.
Enough amniotic fluid surrounds the fetus that an adequate sample
can be extracted for prenatal genetic analysis and paternity. The procedure carries a slight risk of miscarriage
about 0.25 - 0.5% (1/400-1/200), as well as a risk of trauma to the
fetus, infection and pre-term labor.
These procedure is performed by an obstetrician
and have risk associated with
them and can be performed in conjunction with other
procedures. Arrangements with your physician to determine
paternity can be made.
-
| Mother and alleged father samples |
$695.00 |
| Each additional person |
$250.00 |
| Turn Around |
2 weeks |
Chorionic Villus Sampling
The general period between which the Chorionic Villus Sampling
is done is about 10-12 weeks gestation which could be either
transabdominal or transcervical depending on where
the placenta is located. A catheter or needle
is used to biopsy placental cells by inserting a needle (abdominally) or a
catheter (cervically) into the substance of the placenta but staying
outside the amniotic sac. A syringe is used to extract about 10-15 milligrams of tissue
and it is cleaned of maternal uterine
tissue, then grown in culture and tested for paternity.
CVS is commonly used to detect certain genetic conditions though it has a
small risk of miscarriage usually between 0.5%-1.0%, according to
the Centers for Disease Control (CDC).
-
| Mother and alleged father samples |
$695.00 |
| Each additional person |
$250.00 |
| Turn
Around |
2
weeks |
|